Direct-to-Consumer Genetic Testing Market Size and Forecasts (2020 – 2030)

Direct-to-Consumer Genetic Testing Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Test Type (Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), Distribution Channel (Online and Offline), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPRE00018484 Category: Tags: , ,

$3,185$5,985

Description

The direct-to-consumer genetic testing market size is estimated to reach US$ 1.715 billion in 2022 to US$ 7.191 billion by 2030; the market is projected to record a CAGR of 19.6% from 2022 to 2030.

Some of the key driving factors for the direct-to-consumer genetic testing market growth are the growing incidence of genetic disorders and increasing awareness about the potential benefits of genetic testing drive the market. Whereas the high cost and privacy concerns associated with direct-to-consumer genetic testing hamper market growth.

Increasing Awareness About Potential Benefits of Genetic Testing

Consumers are increasingly driven by self-curiosity and empowerment, reflected by increased awareness of services that offer genetic testing and follow-up counseling. Awareness and acceptance of genetic testing are steadily increasing among the population worldwide. The shift from passive to empowered and self-aware customers is driving the genetic testing market. The inherent accessibility of direct-to-consumer genetic testing (DTC-GT) is a major advantage, giving consumers free access to their genetic information and personalized insights and recommendations. Many industries are seeing a significant increase in customers seeking tailored products and experiences, with an increased willingness to pay to identify and meet individual needs.

Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the condition. The role of genetic testing in all areas of medicine is rapidly increasing. Genetic testing is already speeding up diagnoses, and it aids in identifying people with a genetic predisposition to highly resilient diseases. Preconception and prenatal genetic testing assist potential patients with reproductive decisions by informing them of their carrier status for genetic disorders.

The increasing awareness of the importance of genetic variations across a wide range of phenotypes associated with different diseases is further expected to promote market growth. These tests reveal whether a person has a genetic predisposition to a particular disease or phenotype of concern, which can be diagnosed as early as possible to initiate the disease treatment. The first sequencing of the human genome and developmets in genome sequencing technology is enabling rapid growth in genomics research. This has also led to direct-to-consumer genetic testing becoming a new service. The global direct-to-consumer genetic testing market has influenced many people as these tests provide valid information about various health risks, personal characteristics, and overall well-being. Further, the rapid transition of the clinical laboratory workforce to DTC-GT is another crucial factor driving the market. For example, according to MIT Technology Review, approximately 8%, or nearly 26 million, people in the US took DNA tests in 2019. That number is expected to rise to over 100 million in the coming years.

Thus, the growing awareness among the population regarding genetic testing drives the direct-to-consumer genetic testing market.

Direct-to-Consumer Genetic Testing Market: Segmental Overview

The direct-to-consumer genetic testing market is analyzed on the test type, technology, and distribution channel. The market, by test type, is segmented into ancestry testing, nutrigenomics testing, predictive testing, carrier testing, and others. The ancestry testing segment held the largest market share in 2022, whereas the predictive testing segment is anticipated to register a higher CAGR during 2022–2030.

The market based on technology is segmented into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held a larger market share in 2022 and is estimated to register a higher CAGR during 2022–2030.

Based on the distribution channel, the direct-to-consumer genetic testing market is categorized into online and offline. In 2022, the online segment held the largest market share and is anticipated to register the highest CAGR during 2022–2030.

Direct-to-Consumer Genetic Testing Market: Geographical Overview

Based on geography, the direct-to-consumer genetic testing market is analyzed for North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. Based on regions, North America accounts for a significant market share owing to the growing prevalence of genetic diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The growing healthcare business sector and the increase in use of direct-to-consumer genetic testing will continue to offer growth opportunities for market in the region during the forecast period. Further, the rising support from government to address growing concerns about genetic diseases favors North America’s direct-to-consumer genetic testing market progress. US held the largest market share in the North America direct-to-consumer genetic testing market. The FDA approved 23andMe’s DTC genetic test in 2022 for a hereditary prostate cancer marker. Direct-to-consumer genetic testing has been gaining significant popularity in the US. According to the US National Institutes of Health (NIH), DTC genetic tests are marketed directly to consumers via television, print advertising, or the Internet. Thus, the increasing prevalence of genetic disorders, coupled with the rising adoption of advanced gene therapies to treat chronic diseases, drives the market in the US.

Moreover, Asia Pacific region is expected to witness fastest growth rate during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.

Moreover, Europe held the second largest market share in the global direct-to-consumer genetic testing market. The regional market is expected to grow significantly in the coming years owing to the rising awareness regarding genetic tests and the rising prevalence of genetic disorders and cancer. Germany held the largest market share in the European direct-to-consumer genetic testing market, whereas the UK is expected to witness the fastest growth during the forecast period.

The rising technological advancements in the past few years have opened numerous opportunities for the direct-to-consumer genetic testing market expansion. The development of customized testing kits for niche therapeutic areas and the rising prevalence of chronic diseases benefit the direct-to-consumer genetic testing market in Germany.

Direct-to-Consumer Genetic Testing Market: Key Players

Under the direct-to-consumer genetic testing market study, a few key players were analyzed, which include Genesis Healthcare Co, Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc, Living DNA Ltd, 23andMe Inc, Genetic Technologies Ltd, Gene By Gene Ltd, and Full Genomes Corp Inc.

A few of the key primary and secondary sources referred to while preparing the report on the direct-to-consumer genetic testing market are the World Health Organization (WHO), FDA (Food and Drug Administration), UK Genetic Testing Network, and French National Authority for Health, and National Institutes of Health

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Single Nucleotide Polymorphism Chips Segment by Technology is estimated to grow at the fastest CAGR in Direct-to-Consumer Genetic Testing Market during 2022–2030

According to our new research study on “Direct-to-Consumer Genetic Testing Market Forecast to 2030 – Geography Analysis – by Test Type, Technology, Distribution Channel, and Geography,” the direct-to-consumer genetic testing market size is valued at US$ 1.715 billion in 2022; and is expected to reach US$ 7.191 billion by 2030 and it estimated to grow at a rate of 19.6% from 2022 to 2030. The report highlights trends prevailing in the market, and factors driving and hindering the direct-to-consumer genetic testing market growth.

The direct-to-consumer genetic testing market growth is due to the growing prevalence of genetic diseases and increasing awareness about the benefits of genetic testing are the key driving factors behind the market development. However, the high cost associated with direct-to-consumer genetic testing is hampering the market growth.

By technology, the direct-to-consumer genetic testing market is segmented into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held a larger market share in 2022 and is anticipated to register a higher CAGR during the forecast period. Single nucleotide polymorphism (SNP) chips technology is a set of methods and tools used to identify, analyze, and study SNP variations in a single nucleotide base (A, T, C, or G). SNP technology is crucial in various fields, including genetics, genomics, and medicine. SNP is the most common genetic variation among people. Each SNP signifies a difference in a single DNA building block called a nucleotide. SNP technology has many potential uses in forensic genetic investigations, including the estimation of ethnicity, human traits, or diseases. Over 50% of human disease-causing genetic mutations are single nucleotide polymorphisms (SNPs). Tests for detecting single-point mutations require significant sample processing, infrastructure, expensive reagents, DNA amplification, and advanced optical equipment.

SNP technology has a wide range of applications, including disease association studies. SNP is used to identify genetic variations associated with diseases and conditions, helping understand the genetic basis of diseases such as cancer, diabetes, and heart disease. In June 2023, Illumina Inc. announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that accurately predicts disease-causing genetic mutations in patients. Hence, the above factors significantly augment the market growth for the segment.

Genesis Healthcare Co, Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc, Living DNA Ltd, 7andMe Inc, Genetic Technologies Ltd, Gene By Gene Ltd, and Full Genomes Corp Inc. are among the leading companies operating in the .

Companies operating in the direct-to-consumer genetic testing market adopt various inorganic strategies, such as mergers & acquisitions, collaborations, and partnerships.

A few of the significant developments by key market players are listed below.

• In September 2023, 23andMe Holding Co. and Sickle Cell 101 joined forces to expand awareness of people’s sickle cell carrier status. The collaboration will include DNA testing and access to 23andMe’s Health + Ancestry Service for up to 1,000 eligible participants, and 23andMe will be providing monetary support to Sickle Cell 101 to support this effort.

• In June 2023, The American Cancer Society (ACS) and Color Health announced a partnership that will provide convenient, accessible, and comprehensive cancer prevention and screening solutions for the highest-burden cancers including breast, prostate, lung, cervical, and colorectal for more than 150 million Americans who receive health care through either their employer or union.

• August 2022, WellSpan Health and Helix, announced a partnership to create a comprehensive population genomics program to improve patient healthcare outcomes by integrating genetic insights into clinical care and research.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Encapsulated Fragrances Market, by Product Type
1.3.2 South & Central America Encapsulated Fragrances Market, by Application
1.3.3 South & Central America Encapsulated Fragrances Market, by Country
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.1.1 South & Central America Encapsulated Fragrances Market, by Product Type, and Application
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis formulation:
3.2.4 Macro-economic factor analysis:
3.2.5 Developing base number:
3.2.6 Data Triangulation:
3.2.7 Country level data:
4. South & Central America Encapsulated Fragrances Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers:
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
4.3.1 Overview:
4.3.2 Raw Material Suppliers:
4.3.3 Manufacturers
4.3.4 Distributors
4.3.5 End-User
4.4 Expert Opinion
5. South & Central America Encapsulated Fragrances Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Adoption of Encapsulated Fragrances from Various Applications
5.1.2 Strategic Initiatives by Key Market Players
5.2 Market Restraints
5.2.1 High Costs Associated with Encapsulation Technology
5.3 Market Opportunities
5.3.1 Rising Innovations in Encapsulation Technology
5.4 Future Trends
5.4.1 Increasing Demand for Natural Fragrances
5.5 Impact Analysis
6. Encapsulated Fragrances – South & Central America Market Analysis
6.1 South & Central America Encapsulated Fragrances Market -Revenue and Forecast to 2028 (US$ Mn)
6.2 South & Central America Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
7. South & Central America Encapsulated Fragrances Market Analysis – By Product Type
7.1 Overview
7.2 South & Central America Encapsulated Fragrances Market, By Product Type (2022 and 2028)
7.3 Fragrance Blends
7.3.1 Overview
7.3.2 Fragrance Blends: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Fragrance Blends: South & Central America Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
7.4 Aroma Chemicals
7.4.1 Overview
7.4.2 Aroma Chemicals: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
7.4.3 Aroma Chemicals: South & Central America Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
7.5.3 Others: South & Central America Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
8. South & Central America Encapsulated Fragrances Market Analysis – By Application
8.1 Overview
8.2 South & Central America Encapsulated Fragrances Market, By Application (2022 and 2028)
8.3 Perfumes and Fragrances
8.3.1 Overview
8.3.2 Perfumes and Fragrances: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.4 Cleaning Products
8.4.1 Overview
8.4.2 Cleaning Products: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.5 Cosmetics
8.5.1 Overview
8.5.2 Cosmetics: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.6 Personal Hygiene Products
8.6.1 Overview
8.6.2 Personal Hygiene Products: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.7 Food and Beverages
8.7.1 Overview
8.7.2 Food and Beverages: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Others: South & Central America Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
9. South & Central America Encapsulated Fragrances Market – Country Analysis
9.1 Overview
9.1.1 South & Central America Encapsulated Fragrances Market, by Key Country
9.1.2 South & Central America Encapsulated Fragrances Market, by Key Country
9.1.2.1 Brazil: Encapsulated Fragrances Market -Revenue and Forecast to 2028 (US$ Million)
9.1.2.2 Brazil: Encapsulated Fragrances Market -Revenue and Forecast to 2028 (US$ Million)
9.1.2.2.1 Brazil: Encapsulated Fragrances Market, by Product Type
9.1.2.2.2 Brazil: Encapsulated Fragrances Market, by Application
9.1.2.3 Argentina: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.2.3.1 Argentina: Encapsulated Fragrances Market, by Product Type
9.1.2.3.2 Argentina: Encapsulated Fragrances Market, by Application
9.1.2.4 Rest of South & Central America: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.2.4.1 Rest of South & Central America: Global Encapsulated Fragrances Market, by Product Type
9.1.2.4.2 Rest of South & Central America: Global Encapsulated Fragrances Market, by Application
10. Industry Landscape
10.1 Overview
10.2 Expansion
10.3 New Product Development
10.4 Merger and Acquisition
11. Company Profiles
11.1 Firmenich SA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Givaudan SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Ingredion Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 International Flavors & Fragrances Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Symrise AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Glatt GmbH
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Ashland Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Direct-To-Consumer Genetic Testing Market Segmentation
Table 2. North America Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 6. US Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 14. Europe Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 15. Europe Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 16. Europe Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 17. Germany Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Germany Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Germany Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 20. UK Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 21. UK Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 22. UK Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 23. France Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 24. France Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 25. France Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 26. Italy Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. Italy Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 28. Italy Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 31. Spain Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 35. Asia Pacific Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. Asia Pacific Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 37. Asia Pacific Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 38. China Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 39. China Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 40. China Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 41. Japan Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Japan Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 43. Japan Direct-To-Consumer Genetic Testing Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)
Table 44. India Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 45. India Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 46. India Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 47. Australia Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 48. Australia Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 49. Australia Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 50. South Korea Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 51. South Korea Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 52. South Korea Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Asia Pacific Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Asia Pacific Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Asia Pacific Direct-To-Consumer Genetic Testing Market, by Distribution Channel– Revenue and Forecast to 2030 (US$ Million)
Table 56. Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 57. Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 58. Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 59. Saudi Arabia Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 60. Saudi Arabia Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 61. Saudi Arabia Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 62. South Africa Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 63. South Africa Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 64. South Africa Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 65. UAE Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 66. UAE Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 67. UAE Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Middle East & Africa Direct-To-Consumer Genetic Testing Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 71. South & Central America Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 72. South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 73. South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 74. Brazil Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 75. Brazil: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 76. Brazil: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 77. Argentina Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 78. Argentina: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 79. Argentina: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 80. Rest of South & Central Direct-To-Consumer Genetic Testing Market, by Test Type – Revenue and Forecast to 2030 (US$ Million)
Table 81. Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology – Revenue and Forecast to 2030 (US$ Million)
Table 82. Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 83. Organic Developments Done by Companies
Table 84. Inorganic Developments Done by Companies
Table 85. Glossary of Terms, Direct-To-Consumer Genetic Testing Market

LIST OF FIGURES

Figure 1. Direct-To-Consumer Genetic Testing Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. Direct-To-Consumer Genetic Testing Market: Key Industry Dynamics
Figure 4. Direct-To-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
Figure 5. Direct-To-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 – 2030
Figure 6. Global Direct-To-Consumer Genetic Testing Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Direct-To-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 8. Ancestry Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nutrigenomics Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Predictive Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Carrier Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Direct-To-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 14. Whole Genome Sequencing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Single Nucleotide Polymorphism Chips: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Targeted Analysis: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Direct-To-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 19. Hospitals & Clinics: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Offline Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 22. North America Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 24. US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. Europe Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 30. Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 37. Asia Pacific Direct-To-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 39. China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Key Country – Revenue (2022) (US$ Million)
Figure 46. Middle East & Africa Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 47. Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
Figure 48. Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. South & Central America: Direct-To-Consumer Genetic Testing Market, By Key Country – Revenue (2022) (US$ Million)
Figure 53. South & Central America: Direct-To-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 54. South & Central America: Direct-To-Consumer Genetic Testing Market Share by Country – 2022 & 2030, (%)
Figure 55. Brazil: Direct-To-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 56. Argentina: Direct-To-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 57. Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies – Direct-to-Consumer Genetic Testing Market
– Genesis Healthcare Co
– Ancestry Genomics Inc.
– Color Health Inc.
– Helix Inc.
– Myriad Genetics, Inc.
– Living DNA Ltd
– 7andMe Inc.
– Genetic Technologies Ltd
– Gene By Gene Ltd
– Full Genomes Corp Inc.

Reviews

There are no reviews yet.

Be the first to review “Direct-to-Consumer Genetic Testing Market Size and Forecasts (2020 – 2030)”